Regulatory Considerations - COVID-19 Pharmacology Resource Center

Supported by

Supported by

This forum has 4 topics, 1 reply, and was last updated 4 months ago by J WC.

- Regulatory Considerations
- Clinical investigation timelines and approval process
  Started by J WC
- 2
  2
- IND Requirements for COVID-19
  Started by J WC
- 1
  1
- EMA provides recommendations on compassionate use of remdesivir
  Started by J WC
- 1
  1
- FDA launches Coronavirus Treatment Acceleration Program (CTAP)
  Started by J WC
- 1
  1

You must be logged in to create new topics.